Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2013) 32 P949 | DOI: 10.1530/endoabs.32.P949

National Institute of Nutrition, Tunis, Tunisia.


Introduction: Prolactinoma is the commonest pituitary adenoma. The aim of this study was to compare clinical, biological and radiological characteristics in microprolactinoma and macroprolactinoma.

Patients: This retrospective study included 33 patients with prolactinoma. The tumor was a microadenoma (<1 cm) in 27.3% (n=9) and a macroadenoma in 72.7% (n=24) of cases.

Results: Patients were female in 84.8% of cases (n=28). Mean age at diagnosis was 37 years (ext: 20–78). Diagnostic circumstances were symptoms related to hyperprolactinemia in 54.5% (n=18), and tumoral syndrome in 45.5% (n=15) of cases. The first complaint was tumoral syndrome in 30.4% (n=7) of patients. Mean progression period was 44.38 months (ext: 0.2–264). Mean serum prolactin level was 4488.35 ng/ml (ext: 31.9–76 915). Mean size of adenoma on MRI was 20.93 mm (ext: 5–60). Comparing microadenoma and macroadenoma revealed that macroadenoma was associated with a higher diagnostic age (39.29 vs 30.89 years) but a shorter progression period (39.381 vs 62.4 months). Tumoral syndrome was present in 58% of macroprolactinomas and in only one case of microprolactinoma while signs of hyperprolactinemia were observed in respectively 58 and 89% of cases. Mean prolactinemia was 5956.40 and 84.18 ng/ml respectively in macroprolactinoma and microprolactinoma. In macroprolactinoma, hemorrhage signs on MRI were present in 37% (n=9), cavernous sinus extension in 29% (n=7), sphenoidal extension in 17% (n=4) and chiasmatic invasion in 12.5% of cases; while a single case of sphenoidal invasion was found in microprolactinomas. Thyreotropic and corticotropic deficiencies were found in 17 and 12.5% of macroprolactinomas.

Conclusion: These results are particular by the relative high frequency of macroprolactinoma. Tumoral syndrome is the commonest symptom in macroprolactinoma. A shorter time to diagnosis in macroprolactinoma suggests the important impact of this complaint on patients motivating them to consult.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts